{"id":991290,"date":"2026-08-06T11:41:03","date_gmt":"2026-08-06T15:41:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/"},"modified":"2026-08-06T11:41:03","modified_gmt":"2026-08-06T15:41:03","slug":"belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/","title":{"rendered":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, Aug.  06, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-2JldTRd18OFFXe_84NJWPzgDQ4cVNiVhgSR6_2xSDNGuA5zQvRzqAC6_HyKi415FDwxMgHsfk0QwWiGLe-OjIe8Op4xIrKLwr6jHuMuJsG6KdcPQsLxN8v7oiY0_c99kX2_V0VJSxUf6vRCOABbVuVv44y937WfDlW5jSuGGUYErcGqJ0uAQyaXoeaRNBAXtZ_awtQFC7wLoYbHX97g-vxagy5LCxYiu_F9eQCjWmcTbZEA0vAe1Q3se32X-nx0LkbzVJKmWa35JxLe7A5i1V-QtOJ4CFCxJkB4HdIEUOrsT-JBR0diSLj55aXLlkfRDhnXVg0kYKME5gSP1XafOafZfaSL-TnDQMFMcjy3lT6dMU6941aHlRhdn-GdrgR7tz-rHTI3kJxRHaJEX1xZabEjp7_S-6SIMUM7h24MSEY=\" rel=\"nofollow\" target=\"_blank\">Belite Bio<\/a>, Inc (NASDAQ: BLTE) (\u201cBelite Bio<sup>\u00ae<\/sup>\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Thursday, August 13, 2026, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the second quarter ended June 30, 2026.<\/p>\n<p>\n        <strong>Webcast Information<\/strong><br \/>\n        <br \/>\n        <strong>Date:\u00a0<\/strong>Thursday, August 13, 2026<br \/><strong>Time:\u00a0<\/strong>4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)<br \/><strong>Webcast Link:\u00a0<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4GEZkzvS6Tky8afzwwFod6_UUGH8r6Gl9S7yMSDMHYTf9u5nhq4GJQYoYQZfAJoOE6aRvLNDDIyDsmwnTUbKRoop-Lj-sO4EJXX_Z7wUKBQ0ha8IE3Xpsmz4z-PataF4OfLk6TudtPm6JBq7-xmhWfL6US8rG7ptyUnsZB7kXXk=\" rel=\"nofollow\" target=\"_blank\">https:\/\/events.q4inc.com\/attendee\/449343673<\/a><\/p>\n<p>\n        <strong>Webcast Link Instructions<\/strong><br \/>\n        <br \/>You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4GEZkzvS6Tky8afzwwFodzhgHst5FWf9Q9wBLPSntXrWxx-5wG4xUkUiBLkoguDZ2MNbLnkTC2f6iGEzE3Sohq5oCmuwlmKkVgnzxMJRg92UFwJm50pcnxv1xh5hIemOMyQUXqcnCiUYd9t-JJ24QxX-fV9euhg5RgKvsYzKHJoJhNP59xs6wJ9vFxm-V_MN2BeGW2-1n3I9FMHLZYvDg2htfuqtmM5D-DkPEPb1YgT_OUKW7Qnob5YQ7GmmW_0zHYqJaTnMuEa9_tZbHNdVEJ6gi0wCTu9r_1AzCSk1tSnUuPu4RkRlgcxK0gGxWnc7yve5dQTmoskecicH93BoESs26kETCeyFajCgMnq9Vtvj_p7vQoUOE9JkgufAhtSwj_bSWqYoZMGu85iXJeTgGvbI7CfIdkJ64ryPbEWSl3FVEqqMEqCxiiTRnD169902Z4EofjpnjAD339lHg0R2lw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.belitebio.com\/presentations-events\/events<\/a>. A replay will be available for approximately 90 days after the event.<\/p>\n<p>\n        <strong>About Belite Bio<\/strong><br \/>\n        <br \/>Belite Bio is a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, such as Stargardt disease type 1 (STGD1) and geographic atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite Bio\u2019s lead candidate, tinlarebant, is an oral therapy intended to reduce the accumulation of bisretinoid toxins in the eye. The Company has completed a Phase 3 trial (DRAGON) in adolescent and adult subjects with STGD1, which met its primary endpoint, and the drug is currently being evaluated in a Phase 2\/3 trial (DRAGON II) in adolescent and adult subjects with STGD1 and a Phase 3 trial (PHOENIX) in subjects with GA. For more information, follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=07h3sPDTRa1HDzgWwAOoOVv0FvU5mPPIv5Yl6jJmWBYSsi6bTyHZzsZ21uO_wEwpwvR1cmmAJx2L91ufUtyS5BbcZcvrQUzyDCalYTZkVPFqCyvAuBj5wq3cF5t99WUE5worMM6LC5e3T6bSLW4M_ZsKf8lLyRKNf-2H9s2VWbTRMdFAAwXfZ6ahBpJgFP6a7N8o3qvnJg8bpUnHvT7IF8AX40JXmpDkY7LFm_j9swEi-cu_IfrzUL6GieG0kf8hnTHGQT6FdoBerUdS9zEW-12Z7tsmZ7NTkSjepw-MZNUbWfCegIGW8bezAYBkrp0wBJ0VljWcUzApMhjuiuImIHSGfP5Mqn8zmxgVQceUp7gt8N5BMH3n2De9mL13NLtsvUFxC6VJ9q6l6Z7Uek4KIxVgTLZs8J3hwM58gXUkljjkhD3Cvzd1x8QRqESEng5W_bLuZo30fb_vmH6M297QSTpYqtXys7z1MdDZM99i7qJURD-EwULO6GwVNV8c1riROgy3jp1a1_4IeFCvMOk6xKkWyV5flC7MlD-eKxKWjPjOfSQoL3XSfy95AoMcmUdBFMncpWUCnOOifc-fTuFDRrdI2fL33xgBYw_pNMLrotF4odvtpK5YX6lHfq6FPv1UP-ZnO4w8frqbdzLG-obF9N3DeP60veBYdLBz13ogmxDnWNh5ysY3ohzOPP9BMRg7Wq5Wb_X-L-NNvYEGg1IyYpPpRYZJ7XndXrPVoWbhibXDURU1Sw1cHLjhC5ZjgTBWbOYB4auyVZRmJQ9v1slOGu81twqV2vfbRXzIpigvaBYXMCbpLltZ4UxfuQHNdkQ5iXmd0LyKX-32ozZDQqNqVYofbBpeNdVnOe0-1L3lzOLr-CL55NxR81XWDpiZZDaxf2JC5DEiqm0yWxVltocMYzVm2acZk3gVl393J5VDkq885JCx7jgxTVsNWfJ8xmYa2o5HFD2k7ejX21Rkaubme3KDPlEwJU-GZIHJ7ZjntNjdTgmpPC7L_O_T4BONS3W0RsnWU5eg5RPrxcBG6S-lw-zGARkZkCoFE6dJr-2sEeFKqrZ4KyBuhDGM1CQpDoTrZ-kgXMgF2gq6E5sq3tTp2Cr0WLhMjPK0NeX8KnoDd3o_ueo3NlAVDEovU6CqtjT6dWke_MjYewSL8TfWxYCEkfnOzucJ7G0Vmo1aCAIb-zpWkTnnmY-woSY-S71DZIrUSWTr_w6m9hUFRFANVcnF3ZBCXt49bfop2HxTeMaYW8pX1Q5O771nx99-TNKsvidR_BsfHCbMflYitM-kOAWefhHk-eDAcYeJE955-_06WzJXNa0_UPC_wDdKCx9sGHxMxArHIr-6_rOaQen25fhUsRxHtmwaROm9G-sdt88bMBkqntBrNUeDnEKD8zVrmIQ_UYw4jlqKsHZuOG4QnZ-AbNkPzTkONpSp-FF2Hlein6v-pmYzydEzlWjlo1IZsUNu_eN0NpD1wXh-j31I8mdwIlQPN7rUa3yavszqUsq0oHM79NGGQvG1U5s_JuLpMfdbZNN_az-TWUiXzV-nkIEjq0OMQVHuIN8HmGzq0bsIX1U9t0b-0-KRF8ebHfri7KYD3pa79cZHTRTZfmY9fGnWOfq31bbep6ao_Sqv0Hd1CmyY3cAuApuSLJYnHqBo0FgemYj16DemmanIWQF3YA9gBRIzWGvdfeIAWuRoa0-RAZGh4s9gUwyzGYQj8OGyx7afMAco9A93MeXpPEQfKhOpUxPLr3F3wh-8wSiDvQDmos9WVgeiJWTcfKq8zupH77409xm-ZImnmXvo26W9tyHXncZ6vzlUiofz81ViovMMgDBDhqFrAS89ScxTtUECd7HmpBIISOKbEToE8vXsN5Ac-jfXKu44avp7bGVkkYOoQb6GiDA_URf6JHiXIBeP71Io\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w6r5maRImpf7hFRr-Z9BOlcUEnRt7Y8DqOF4yx4BjvkUNM7EzWm-o0QdqFyjQymVObEP6q_aNKBR-8Tb_v3sVFsMNTiGPObXUtY4kl_UIQqN81VvBpdT2XsEM6zVcwKYZW4R3vQ2l1-pf0Ic9fm2ONWUjJkgk-cG_s68KUOMHUAUGrcUsHYG1tQ_7MGQRz25iQ5I0jusqNKTGf6fF2gw2ugY6nxFYZXoGztwCaavJzV0cnp9eSwIRl585dPmLGdRlRGZC4trd7j6QzVsuEjFSc4B7yI_EGdazCQcKRWVjkJZNljVQQ3N2qxfpwLz1Q63Y8R77PtPAeg6Rh1akT88kpJSPo2M-IDT3XyVmmsw5l4LvkzngRXeDszbTO8CHsA1Kiw7we4svoNAfnzOqU52UOfBz0marYf0yvxoObw3rNdzqnvWwsGhk0AVJczva7JBwihcmFIVv7mMjFs0E0dlW3ZYHEIoRMaCtbdrUdAPmH4zta5EQl94koDu-HNsA5jMjpmMSumd3s0K8TeU7T00d6ZyNKMdAml6NXM8tbGvFRzUWxstcDDvG-5foao-fFriSxaBAoUw3dbkGQ3vNML_dSXCcjYbm-HcpvomFMlMF1e6tJ8YH3IXd1nObjfJpQ9DPquyeDptTdS7smUdZNdsmNOh2l1QO-c2KjTD_D_j2f2RYT8rMqmHxa2UsqTeoyrG5LU6fqM4gvgbuHUTSWan6yYmwIVUrzCqli6HpcFmBxcaHyYxMxOUY8f2BZqgkQoMalbSNMpdwW4ahsuLLAYGaGhxDFh8ouX4WusUM1o0g9B6zkxmPTP8tPyzcCgPBhItXZzKCSA1Co2D2u-drqnCPK_qmx7sEyNAoeRHbeeleEPSAxtGZBY9mKoaJkiDdmv84FjjbTiMHEYEMrgbsG7mnOHHyJmX14-cxDVe0tGI8iGvDkjm1Cv54jEHiv14QHQBxI-J8Z-ciY1dM8Eftg820b1uI5lR5toVgfk13YlYyKgEVoogEft3M31MCP59aVicOaTmD781yCd7BWpSgWGUpWjjqwKGxs6JGQtjAlhQ_7s5PKtYfSMaeRYWwONoG9kDmmXVmg2KepL26T6JyAjBi2p1REog2fPhaeayGxhiRg13VJkA213fSKGX-Sl9e1GvCab2bVY7GqbZoc5Y9NnywCBgsCXEs3TAvyv4ImDUdhn8Ld-TWVtfqeFSGaoQ0dhkC67oZ9ddf6uaVjpzQ5xCBFKb0bhv6EIqlG6fGN4QKKklRekPARPoAYpEtd5OnxlY5Bfte8PjhVOy-JZ0jaYFNHkcyCed1E9JnQl5hefdj9fWpPAsDamXNzFIDX__HDjn_E7fqy6HmYkM-5y8Rt0EDAm_kqrVwpWovt0V4bvWRtxepKA_DFrJzKhVV-voVuC4F5fJui09IfAzfhmo2Hy70krWd5eI2U9dcBmTEE_lsLcMlQrACYhqOhrvTHkemIBdcUKTK39_jK9Rsgzm9nEylrVJdr15NLLBuOKPW7NMoFvtv4Ei5DMTGR0DvZWdJG-kNE59C4GJu3vLULB-_RguRrVpRzlqEM3mvlJhGdo9bSH_b5NZVtmraRt2RIOv6fvJYFg8oQyqbtqSMDE1HDXAGmfEAiOX43exEpNSGCjNywLXKVD6zxpe9a9MVLC78noCKDvis7vl9l9X1hE0MgJwi8oGoEjFBse1K94CT5nEhQqcQcfr4tbsOIAgTeDToffJeEpKNzTjxwccF0BipDVYUXRcCnJIaPyfY4fdMILc6FGYXCRTOfz9_Nxh49W5F475yVomUc0H09gX8_JMLzmF7pPL9I5FCIJTVk45xASrWMQ0rHJtYlm91v_uaRCKRqwg7Uy8tpjw7fa2Ue6YZVYS9HNQzRDy2-HDc77yZqXOqB-tyQQoD3i-uofNULX60LdgsDWeDBo9USuMpMaW4KzWEKpxes0gnmfL6kxdCZzDt3eoLrBfE4cN1SrGCNxZfKb1k7WlcG9NFr3pY32M4g78JMOmIcIjfqqqSzEQIoNzOzlVxjmI8Ee5oMDsZkwn4k381tvLI_1vywEraatpreO_DLqcdcf_6O1A3hvkjzb2WcQpbHOsg1Sg_f6IsupPWbgSQiImcd6EdOFP8KDBzJp3GA==\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U_vUQIyr4UVRbPeyXylDd32x07Mb4azOhI52FaqClDaSMQNGjFZWKUeGKW3oPG2lGA4_NDhy1w_BGSOKBjWDp3AwDOlO_ZqDVYlOcc9y2wMJykJD9NoaWqeL0dqs2F20PGyTK0NIqUtpV7yLYd1RvP_k7-tkouagTAu9PaTG1IdWfzb4rAufQ8qsVqMl_ESGQ3zpaTOkP5dINOfx_gJJCjkwazowFh1UQZLXuBFgnz3tGRTaY4MaJFxx-gMmraPsQ4VCWb7eyzKEJmyCE0gLnnO6hg1mKOL4FUZWO8kubV4SsrhgwS5VwR5EtlLkANGadXQkwc_W0_fDyXeRoAclEkllQShtHgX2uka1nq2FqhIpc1aRU5ZSys0Wo4cOHKKcM63nSWKyuMEg0RH86z9ZIJY-hejM438-Hj194OX-949os0tI44qH96vS5C4ONkWdjUlWK5NcWaYWahsViUaR5XHSAZ9_1lBTljYs2wZ0kDAe6tbO0g8k4CALZsaOSY452AqyXJ0uJfqaN2EE5tkaFB9LiBnX5vGHyF2wKobauruyNiB8B4Vwu5pUdsIYbiqppFskxP7O4qAiBsovd0dRkFOjtFqsUMCWmuBRCcNlrtHTHYfuL5VUQ8ieFs_L-35O9IAe630Sy2nw_GEEpcaM-7aoFIcPB3aTvIU_JcgIEZdafsJwp_OKoUtMcuCwr9gmCweIEA1hZS0Z1DPbEsD-kKBTv0aRTmqyzybUM1xhuTftBS4WxAG5lfle-nlHK7ie3K6Ukq3vC7vpwOJWOA5LVe2enQ9lbP0lsO1HKsehT5AwmOYVR6La0w4k3O4rmOS8zdvfcOLn9tW5MAd46BnCButnDjdiLgu9cKSFDHAhZn4Cmi0rAGW5QUh3hcRmUgMJEtKoDQMJKlkAZGkobJGYuEVl50BH2pyyCcJQISR_pN5J2tSKpld2zbUznByLcVZPmpaUKw_ZVfENOHJ8u8SayqdoZfg8328owQmD7Ha88tilj_C_mzbP0MFLmcVgBJsL-RmiYELJX332M19NA417FBhLpeTGOFGHncN3fx1focIMDoc9E17UtjHOiGuc9dpZatCyj5b-7WuCT4vKXxERxOutbtZnbWg9tZ_GmIjUElMEk1EQy-LySF1mFzjR0pVz5YFAT2OBhBxU_8ip4RtD1G1clWuRvGDNZ3aWSMQUKTV9OtEf36g5FIwm8841Gis4j99iKKsM-o2KQSwRt5nmsix6fAcOdODNIDmWM_YzPPpKQB3c6cNnyz5zFJ-t0OFdsPZvhhFC0ivGtuyVNTlRud7yP6unSw0cexfEK4Hcau0uZ22ob6jMpBVvdqjkYPJbFyFiblNtCm89-Op0l77e_5OL9zzl2g7VlHUysmUwS0E6sfVg4HB58AnA579lZrEHot45kUk-rF8Z-HGsKcxRTAzszf0tJzVoQa6BpwI8Qg3Bgwn1GHIQh36AxrWb884JpBBWPS2WQHi0WpujThS9a0c-A7ZoSkM8-AoNxzT91svCF3RvubeeUdY4r6E-_QTcLJIxWdkpggeS_d5xqFMotvtJUOsSw1J_KX0gCGudCHXMcUz6wjtqesR2ypeA8vqDP-MIAX4ZXptoPEx1f196f2HIRVPaafxmUVDVSKAjCTYReL5oSJ8mmHbdZB1GA0TuF6Ks197OB18drs8yYulFvVIC7AI1MQvJDkygDQNvuHhSs0toP3-1dvIg3GQT_QczV0xtdE4OuZN7NDGfWBjsNyV0LcHuZNLwWYRWIEdYrSytb5jbAF8bz2CFVsleYJrpXG0BKvVE-7Zup0n2MWKUT7ATJZ42u6jsB0O9TK57fZde3ba4fVUlhGhhwENGpYss0dsXVsRhL88XV_crkFZyfq-e7g4_IznZNCC4AJFO4fFZw_gzgGNZHKkmLXwiPF54mzKeKCEv0I1Zm4XW-JJSAEpNYIiNEDYsESMZ1s66wiVyoO9Zru3ORv15sie-R5DAp-s-Ic5GyRxDaezKpEQNCWVOv1Ay61MzCUoro1fciEsqxh4rSvB77_gEhs8YIe1iLEBxJ2ejDPA1S6rO2CKlPrCV5EY-h_6ElkGq8TvtNF3Ivn--Q-h7eOwqZvtJLLAbD7ZZGTIKi8CjLb0s9BzTLQ==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uPQkiwV6OgC0wQvbsELJcVks5Bi7UbyrtehdDCU5uxeflnf-8pBTBEwVCCxHAV6-TfnEJb_5SUSBr9d3IyEoDT2wONpZvtC0WBzI2BaZnh4iPqT3u3niTrI1paZ2_BaumWSXUJTvxQy4mF6fPhAm0oiphMuXV9Jda7UwOoNy98v36El-Pf5huqcD6gooHIapfwpGmeRFYrpDsHwEpLcNnTc-B7wX7w8s3eOV40eLYaR4Jo0xHrsjezqR7fY2XqbMhYkHs2W_ZFC8nbYGWNeutVeN900cEoFbBE1Gt3bqDOTMpToK2tuc-TSmIalgmr7IMdyiv1fKznuV5wWr8sXVHPWay18G2lkYZ1sj92-HkfwHAsjJLhBLAcK1QTN4iKD6yQnEVl2vtf-RieVr0BhhC8_SNmbBmxlmg62pT1eG7vaRc5dQaEcE3cfRZPlbUZKy4zIYuvKbV6VhA5NYXKHmn4Ujx4GA9SsxdzVEMmCvqqbpCVIK1YYVxOU3VuaIPBzzH8npq2tnQjyeGbSkXl68x6ugDNy17ZQpbUWslxKRur036DRn9lHxMmXZ4_5yGXqSKGfqx_OcqbkuFriKTi1mkkEXOEuSxZFam-8EPcoAC101EXsW8ONwIoECL7aik8Mtsx4AoixlP16Y4rOAZtfTzKySa9Nydqm1RD8EC50caj1e94hOdnWp_18HxyuqOBohsWRvz_Z1TRfUiNqsFiA5qpForWLUhVeMvlhwZ_UdKDI0eaz3m8tU_3EA35-6ok_McSFK40rXW_8C9BjHimGjy0ztqB91o85N4EX78cFHftIVfaOb2vXd7_QqUHw0psFNmuYQjFMBl2G21WYP4Sy7mqYf87RzrXSAjQhaRJuWEcPIzhBv7JTzS_f2Ltzk8vFbssi2wOnSLSC3zl45603eKr9yK_og-jgNIii_I--9HOjnWrudB7ODrj4vrr9W2HgWsFezK70aT2AgLNF-94ru_iStseDvMBxTllbXRWYPUPxO6S-6_q4t5lY7MYR1dNLf1TUAKAi0Rl2MBGpfVsPpwBXRaypZa4SqXL0cib-eiqxiuBhEA6ZlLDeud42fy3taTDt-wa0J3UHfR7inAtw3i-SDSOZjKffMoxPXZX0vtmtEqazGjYJQG5Wvcz99uUpHiDaXXB8tBVTGQbjEsTTZdOeVCPY6suXyWD0Weu_-wIw7ojughgA50kA646fFa_8fDKEA-cXNdeOYhpQ4oyFe-Av6jU2qo2H5okV32w6pG5CfLj5YdMshdIUThC1g71dCzgG2fCMUlh36fGcKDQfnhSMk5HPAQhw7rzUZGYVjTTySEyR2XhUFXMVkMoTrOEEL7q95hYi0ADT-pdHZR7ncaCHzaFZqtbYFz73pTiYzb2KWvzDyQzlHOAk1Px3R7Zkcoh6gBUs_RHjnfSpJuyh2sLijEC6sP2VB4JrClKibEdIWWjr01CQyJ-BHvkNOOuqtCnfloT8yFSd-XmgBIFAgpHP1DQdM0anxZdNLKvxgR_PD8I8fNsI2thZZnhCn3M0rB_4xucAODuEhlHWFSnwy0qO0G2VJpJT8yJm3SN9q3_f2StJwLDP4y6apZ99ceQgYHzBNZBxBIlGfpr5tUwV3NCsJo_YYbbXVRR7GA5X78TyBZ0xJwCxOqwhRN5GJnV95DIYtH9q95D_A5SD2hfVQRDrp5rG7a9Q8tsOR6GSBlzj2TL0UeJTNME7UtoY7n1pM3Lt7GJz0PMGdQdqOSfKFUr_1vzrF6zH9VLhpu-oSUUEpjyqgNRXgH44nkgOO_QbmRKxJKaj7-9BC9Md0ON8Vx3G1YtYLrZIV5brXf4GQG-cvdSwhLandJtzIg1n-dZPr1V4YdwWIv-Q7SQiZXSA3XPbr690FC6U3nrUNDAxJBb9-Zvly4TIbmOpqwmGzqjCw-GHytw-aLkkFEXEc8Y1vTtO3bzBoZ9TlvtcOtRP8C6OW3wYLx_owwC0uNRiA7KkErn791s-pOzm9KV-DWjKeiydDN3cyOB3yH_6La3YZxfqTvwDDTy-uxp624FGzB53S_90LX2L-AxUa76ZoPtT_WTF7jOAv-wkoX0jepX629QIJPCrw1kq9rG9oAsOf4_piRY7WD8aphfaILuUhhq9r5Q==\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, or visit us at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7hUtAILJ22gqjgzJiA3BOqopAfgsot57fa8oHn6p6c3sTUiuN0-zbMFBDCyMgeXUTfotFEh44_SDa0hgxpdFKWP2PX8ai8VWm2nthWFF7f1cCMhWbq49fsdStqRUIOIltPkQnGJLcY87jk0h9UI3NlmrysNYuWtyjvOv549rIDfXWdCaWCEg-5Mz8A8Cwc8mDalsoyepoWZVCInR7cpzYzM6E-6-MyjW85YFDg_3gGWF-xylYDnxcmhyJREqyIvWLlkw0g2-A6ZZyroitIk0jA_oNERgGUVno_weI05_wdWGkR-oa0L13pGNo9LN3u3OaP5-LuhAC7wT2TGgQGs-NXDxmxL2VBzyTbPb2flXpkAdP1kS9CTNebS3qacJDudypZ7LohLN3AL6-JjO8BNw_X2_G-T-z2HrpxF5pKoPuGMnyNKZ_N3tlE4Skrrz1QKd2gJ9uzmHXrlYjCsCa8X5gwZD7Xm0WnjCU7yMVSjj4s8tcXV_Fy1Ha9cDKOLYBiYrZTR6LfcEIopudB6gS7yDk0n0d79P2jmJPcT1z96qfys5Le5GgBuBdzNFJ7EQvgGgSQv9P66yDrLGyCd0QnrQGmmDmRsoSJqNEwZQXu9uTrKUyAWZGVJvYR1hkmbeM2T6EMYO49w9CrMrFFyI2uJ7suA0Oc4ekjBio8YgNBIQ5Ap7R9dk_PGAJynukPurAJQxhgJbSvdzaTWQLvO1qUvXNwYLQz_DiwUWuN8_dULxWPEettDB63en3OrJzLIaGmmhPyVdvECxMddonxX6imj23w==\" rel=\"nofollow\" target=\"_blank\">www.belitebio.com<\/a>.<\/p>\n<p>\n        <strong>Media and Investor Relations Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9FvnOe-kc9wLYAa8znpbXzrSumMglBor-uW7GaBU7Xerh5oUG6GnWjYjru1jWAT0yJnjuLiR3FzUYIY6hiUFO6G41DsRASADTNO5Z4ABtWTElCBSql68jFXmTic2ujKY2edml1c_8UHUA0Og9EdnPWBbckrM6vqxDiPARGFRh2wVZHkwBSFyaTS2cnyX8PGo5DralpuEBNa5r4PJ5GEZVTv0gPlo2MXXdvpURpQsJ0lNS-lEU7j_0WSDCgqdHU3rwBwtBSXP2K7rdT22tZHD2g==\" rel=\"nofollow\" target=\"_blank\">ir@belitebio.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Zjk5ZGU2OTMtMjE1YS00M2YzLWJlNmQtOTZmNzg4ODI3NWJjLTEyNDUyODUtMjAyNi0wOC0wNi1lbg==\/tiny\/Belite-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u00ae\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Thursday, August 13, 2026, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the second quarter ended June 30, 2026. Webcast Information Date:\u00a0Thursday, August 13, 2026Time:\u00a04:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link:\u00a0https:\/\/events.q4inc.com\/attendee\/449343673 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-991290","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u00ae\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Thursday, August 13, 2026, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the second quarter ended June 30, 2026. Webcast Information Date:\u00a0Thursday, August 13, 2026Time:\u00a04:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link:\u00a0https:\/\/events.q4inc.com\/attendee\/449343673 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay will be &hellip; Continue reading &quot;Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-06T15:41:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results\",\"datePublished\":\"2026-08-06T15:41:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/\",\"name\":\"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=\",\"datePublished\":\"2026-08-06T15:41:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results - Market Newsdesk","og_description":"SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; Belite Bio, Inc (NASDAQ: BLTE) (\u201cBelite Bio\u00ae\u201d or the \u201cCompany\u201d), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Thursday, August 13, 2026, at 4:30 p.m. Eastern Time to discuss the Company\u2019s financial results and provide a business update for the second quarter ended June 30, 2026. Webcast Information Date:\u00a0Thursday, August 13, 2026Time:\u00a04:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link:\u00a0https:\/\/events.q4inc.com\/attendee\/449343673 Webcast Link Instructions You can join the live webcast by visiting the link above or the \u201cPresentations &amp; Events\u201d section of the Company\u2019s Investor Relations website at\u00a0https:\/\/investors.belitebio.com\/presentations-events\/events. A replay will be &hellip; Continue reading \"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-06T15:41:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results","datePublished":"2026-08-06T15:41:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/","name":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=","datePublished":"2026-08-06T15:41:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTEwMCM3NzYyODUzIzIyMzM3MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/belite-bio-to-host-webcast-on-august-13-2026-to-discuss-second-quarter-2026-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/991290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=991290"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/991290\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=991290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=991290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=991290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}